A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours (Q35677661)
Jump to navigation
Jump to search
scientific article published on 30 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours |
scientific article published on 30 September 2014 |
Statements
1 reference
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours (English)
1 reference
M A Rudek
S Ahmed
D A Laheru
D Cosgrove
R C Donehower
B Nelkin
D Ball
L A Doyle
H Chen
X Ye
G Bigley
C Womack
30 September 2014
1 reference
1 reference